CLIN MOL HEPATOL 2019 10.3350/cmh.2019.0006
An integrated analysis of elbasvir/grazoprevir in Korean patients with hepatitis C virus genotype 1b infection
Lee1, YJ; Heo, J; Kim, D; Chung, WJ; Tak, WY; Kim, YJ; Paik, SW; Sim, E; Kulasingam, S; Talwani, R; Haber, B; Hwang, P

Cancer Med 2019 10.1002/cam4.2570
Clinical significance of radiotherapy before and/or during nivolumab treatment in hepatocellular carcinoma
Yu1, JI; Lee, SJ; Lee, J; Lim, HY; Paik, SW; Yoo, GS; Choi, C; Park, HC

J GASTROEN HEPATOL 2019 10.1111/jgh.14750
Hepatitis B virus DNA levels and overall survival in hepatitis B-related hepatocellular carcinoma patients with low-level viremia
Kim1, TS; Sinn, DH; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW

SCI REP-UK 2019 10.1038/s41598-019-50594-2
Prognostic significance of miR-122 expression after curative resection in patients with hepatocellular carcinoma
Ha1, SY; Yu, JI; Choi, C; Kang, S; Joh, JW; Paik, SW; Kim, S; Kim, M; Park, HC; Park, CK

J GASTROEN HEPATOL 2019 10.1111/jgh.14856
Non-alcoholic fatty liver disease and the incidence of myocardial infarction: A cohort study
Sinn1, DH; Kang, D; Chang, Y; Ryu, S; Cho, SJ; Paik, SW; Song, YB; Pastor-Barriuso, R; Guallar, E; Cho, J; Gwak, GY

EUR J ENDOCRINOL 2019 10.1530/EJE-19-0143
Lean non-alcoholic fatty liver disease and development of diabetes: a cohort study
Sinn1, DH; Kang, D; Choi, SJ; Paik, SW; Guallar, E; Cho, J; Gwak, GY

Oncoimmunology 2019 10.1080/2162402X.2019.1615817
Vaccinia-based oncolytic immunotherapy Pexastimogene Devacirepvec in patients with advanced hepatocellular carcinoma after sorafenib failure: a randomized multicenter Phase IIb trial (TRAVERSE)
Moehler1, M; Heo, J; Lee, HC; Tak, WY; Chao, Y; Paik, SW; Yim, HJ; Byun, KS; Baron, A; Ungerechts, G; Jonker, D; Ruo, L; Cho, M; Kaubisch, A; Wege, H; Merle, P; Ebert, O; Habersetzer, F; Blanc, JF; Rosmorduc, O; Lencioni, R; Patt, R; Leen, AM; Foerster, F; Homerin, M; Stojkowitz, N; Lusky, M; Limacher, JM; Hennequi, M; Gaspar, N; McFadden, B; De Silva, N; Shen, D; Pelusio, A; Kirn, DH; Breitbach, CJ; Burke, JM

J HEPATOL 2019 10.1016/j.jhep.2018.11.029
Sorafenib with or without concurrent transarterial chemoembolization in patients with advanced hepatocellular carcinoma: The phase III STAH trial
Park1, JW; Kim, YJ; Kim, DY; Bae, SH; Paik, SW; Lee, YJ; Kim, HY; Lee, HC; Han, SY; Cheong, JY; Kwon, OS; Yeon, JE; Kim, BH; Hwang, J

BMC CANCER 2019 10.1186/s12885-019-5508-5
Late presentation of hepatitis B among patients with newly diagnosed hepatocellular carcinoma: a national cohort study
Sinn1, DH; Kang, D; Kang, M; Paik, SW; Guallar, E; Cho, J; Gwak, GY

PLoS One 2019 10.1371/journal.pone.0213547
Hepatocellular carcinoma with extrahepatic metastasis: Are there still candidates for transarterial chemoembolization as an initial treatment?
Kim1, J; Sinn, DH; Choi, MS; Kang, W; Gwak, GY; Paik, YH; Lee, JH; Koh, KC; Paik, SW

PLoS One 2019 10.1371/journal.pone.0210730
Multidisciplinary approach is associated with improved survival of hepatocellular carcinoma patients
Sinn1, DH; Choi, GS; Park, HC; Kim, JM; Kim, H; Song, KD; Kang, TW; Lee, MW; Rhim, H; Hyun, D; Cho, SK; Shin, SW; Jeong, WK; Kim, SH; Il Yu, J; Ha, SY; Lee, SJ; Lim, HY; Kim, K; Ahn, JH; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Joh, JW; Lim, HK; Paik, SW

EUR J GASTROEN HEPAT 2018 10.1097/MEG.0000000000001226
Additional role of liver stiffness measurement in stratifying residual hepatocellular carcinoma risk predicted by serum biomarkers in chronic hepatitis B patients under antiviral therapy
Song1, BG; Sinn, DH; Chi, S; Kim, K; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW

ANTICANCER RES 2018 10.21873/anticanres.12808
Treatment of Naive HCC Combined with Segmental or Subsegmental Portal Vein Tumor Thrombosis: Liver Resection Versus TACE Followed by Radiotherapy
Yu1, JI; Choi, GS; Lim, DH; Lee, E; Joh, JW; Kwon, CHD; Kim, JM; Kim, S; Woo, SY; Paik, SW; Park, HC

LIVER INT 2018 10.1111/liv.13732
Validation of the Baveno VI and the expanded Baveno VI criteria to identify patients who could avoid screening endoscopy
Bae1, J; Sinn, DH; Kang, W; Gwak, GY; Choi, MS; Paik, YH; Lee, JH; Koh, KC; Paik, SW

J HEPATOL 2018 10.1016/j.jhep.2018.01.024
Hepatobiliary MRI as novel selection criteria in liver transplantation for hepatocellular carcinoma
Kim1, AY; Sinn, DH; Jeong, WK; Kim, YK; Kang, TW; Ha, SY; Park, CK; Choi, GS; Kim, JM; Kwon, CHD; Joh, JW; Kim, MJ; Sohn, I; Jung, SH; Paik, SW; Lee, WJ

SCAND J GASTROENTERO 2018 10.1080/00365521.2018.1458895
Treatment for occult hepatocellular carcinoma: does it offer survival advantages over symptom-driven treatment?
Kim1, KM; Kim, J; Sinn, DH; Kim, HS; Kim, K; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW

DIGEST DIS SCI 2018 10.1007/s10620-018-4934-6
Novel Albumin-Bilirubin Grade-Based Risk Prediction Model for Patients with Hepatocellular Carcinoma Undergoing Chemoembolization
Kim1, JH; Sinn, DH; Lee, JH; Hyun, D; Cho, SK; Shin, SW; Chang, Y; Kim, YJ; Yoon, JH; Kang, W; Gwak, GY; Paik, YH; Lee, JH; Koh, KC; Paik, SW; Choi, MS

ANN SURG TREAT RES 2018 10.4174/astr.2018.94.4.183
Prognosis of preoperative positron emission tomography uptake in hepatectomy patients
Kim1, JM; Kwon, CHD; Joh, JW; Sinn, DH; Choi, GS; Paik, SW

SCI REP-UK 2018 10.1038/s41598-018-23014-0
Nonalcoholic fatty liver disease accelerates kidney function decline in patients with chronic kidney disease: a cohort study
Jang1, HR; Kang, D; Sinn, DH; Gu, S; Cho, SJ; Lee, JE; Huh, W; Paik, SW; Ryu, S; Chang, Y; Shafi, T; Lazo, M; Guallar, E; Cho, J; Gwak, GY

NEW ENGL J MED 2018 10.1056/NEJMoa1702417
Glecaprevir-Pibrentasvir for 8 or 12 Weeks in HCV Genotype 1 or 3 Infection
Zeuzem1, S; Foster, GR; Wang, S; Asatryan, A; Gane, E; Feld, JJ; Asselah, T; Bourliere, M; Ruane, PJ; Wedemeyer, H; Pol, S; Flisiak, R; Poordad, F; Chuang, WL; Stedman, CA; Flamm, S; Kwo, P; Dore, GJ; Sepulveda-Arzola, G; Roberts, SK; Soto-Malave, R; Kaita, K; Puoti, M; Vierling, J; Tam, E; Vargas, HE; Bruck, R; Fuster, F; Paik, SW; Felizarta, F; Kort, J; Fu, B; Liu, R; Ng, TI; Pilot-Matias, T; Lin, CW; Trinh, R; Mensa, FJ

LIVER INT 2018 10.1111/liv.13489
Non-invasive tests for liver disease severity and the hepatocellular carcinoma risk in chronic hepatitis B patients with low-level viremia
Paik1, N; Sinn, DH; Lee, JH; Oh, IS; Kim, JH; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW

J INFECT DIS 2017 10.1093/infdis/jix506
Nucleos(t)ide Analogue Treatment for Patients With Hepatitis B Virus (HBV) e Antigen-Positive Chronic HBV Genotype C Infection: A Nationwide, Multicenter, Retrospective Study
Chang1, Y; Choe, WH; Sinn, DH; Lee, JH; Ahn, SH; Lee, H; Shim, JJ; Jun, DW; Park, SY; Nam, JY; Cho, EJ; Yu, SJ; Lee, DH; Lee, JM; Kim, YJ; Kwon, SY; Paik, SW; Yoon, JH

J HEPATOL 2017
Development of chronic kidney disease in patients with non-alcoholic fatty liver disease: A cohort study
Sinn1, DH; Kang, D; Jang, HR; Gu, S; Cho, SJ; Paik, SW; Ryu, S; Chang, Y; Lazo, M; Guallar, E; Cho, J; Gwak, GY

J GASTROEN HEPATOL 2017 10.1111/jgh.13796
Daclatasvir/asunaprevir/beclabuvir, all-oral, fixed-dose combination for patients with chronic hepatitis C virus genotype 1
Kao1, JH; Yu, ML; Peng, CY; Heo, J; Chu, CJ; Chang, TT; Lee, YJ; Hu, TH; Yoon, KT; Paik, SW; Lim, YS; Ahn, SH; Isakov, V; McPhee, F; Hu, WH; Swenson, ES; Yin, PD; Treitel, M

DIGEST DIS SCI 2017 10.1007/s10620-017-4775-8
Liver Function Assessment Using Albumin-Bilirubin Grade for Patients with Very Early-Stage Hepatocellular Carcinoma Treated with Radiofrequency Ablation
Oh1, IS; Sinn, DH; Kang, TW; Lee, MW; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW

SCI REP-UK 2017 10.1038/s41598-017-12469-2
Clinical importance of TERT overexpression in hepatocellular carcinoma treated with curative surgical resection in HBV endemic area
Yu1, JI; Choi, C; Ha, SY; Park, CK; Kang, SY; Joh, JW; Paik, SW; Kim, S; Kim, M; Jung, SH; Park, HC

HEPATOLOGY 2017 10.1002/hep.28916
Low-Level Viremia and the Increased Risk of Hepatocellular Carcinoma in Patients Receiving Entecavir Treatment
Kim1, JH; Sinn, DH; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW

GUT LIVER 2017 10.5009/gnl16403
A Novel Model for Predicting Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B and Normal Alanine Aminotransferase Levels
Sinn1, DH; Lee, JH; Kim, K; Ahn, JH; Lee, JH; Kim, JH; Lee, DH; Yoon, JH; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW

KOREAN JOURNAL OF INTERNAL MEDICINE 2017 10.3904/kjim.2016.096
Long-term real-world entecavir therapy in treatment-naive hepatitis B patients: base-line hepatitis B virus DNA and hepatitis B surface antigen levels predict virologic response
Cho1, JY; Sohn, W; Sinn, DH; Gwak, GY; Paik, YH; Choi, MS; Koh, KC; Paik, SW; Yoo, BC; Lee, JH

J Gastroenterol Hepatol. 2017 May;32(5):1064-1070. doi: 10.1111/jgh.13637.
Proton pump inhibitors do not increase the risk for recurrent spontaneous bacterial peritonitis in patients with cirrhosis
Kim JH11, Lim KS1, Min YW1, Lee H1, Min BH1, Rhee PL1, Kim JJ1, Koh KC1, Paik SW1.

J Gastroenterol Hepatol. 2017 May;32(5):1100-1106. doi: 10.1111/jgh.13647.
Insulin resistance and the risk of hepatocellular carcinoma in chronic hepatitis B patients
Kim JH11, Sinn DH1, Gwak GY1, Kang W1, Paik YH1, Choi MS1, Lee JH1, Koh KC1, Paik SW1.

J Gastroenterol Hepatol. 2017 May;32(5):966-974. doi: 10.1111/jgh.13709.
Urgency to treat patients with chronic hepatitis C in Asia
Kao JH11, Ahn SH2, Chien RN3, Cho M4, Chuang WL5, Jeong SH6, Liu CH7, Paik SW8.

Gut. 2017 Feb;66(2):323-329. doi: 10.1136/gutjnl-2016-311854. Epub 2016 Sep 6.
Non-alcoholic fatty liver disease and progression of coronary artery calcium score: a retrospective cohort study
Sinn DH11, Kang D2, Chang Y3,4,5, Ryu S3,4,5, Gu S6, Kim H6, Seong D2, Cho SJ7, Yi BK2,8, Park HD9, Paik SW1, Song YB1,10, Lazo M10, Lima JA10, Guallar E10, Cho J2,3,5,10, Gwak GY1.

Aliment Pharmacol Ther. 2017 Jan;45(2):345-353. doi: 10.1111/apt.13866. Epub 2016 Nov 18.
Non-alcoholic fatty liver diseases and risk of colorectal neoplasia
Ahn JS11, Sinn DH1, Min YW1, Hong SN1, Kim HS2, Jung SH2, Gu S3, Rhee PL1, Paik SW1, Son HJ4, Gwak GY1.

Medicine (Baltimore). 2016 Dec;95(51):e5666. doi: 10.1097/MD.0000000000005666.
The utility of gadoxetic acid-enhanced magnetic resonance imaging in the surveillance for postoperative recurrence of hepatocellular carcinoma
Kim JH11, Min YW, Gwak GY, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW.

HEPATOLOGY INTERNATIONAL,NOV 2016,10(6):947-955,DOI: 10.1007/s12072-016-9726-5
A phase IIIb study of ledipasvir/sofosbuvir fixed-dose combination tablet in treatment-na < ve and treatment-experienced Korean patients chronically infected with genotype 1 hepatitis C virus
Lim YS1, Ahn SH, Lee KS, Paik SW, Lee YJ, Jeong SH, Kim JH, Yoon SK, Yim HJ, Tak WY

Dig Dis Sci. 2016 Nov;61(11):3354-3362. Epub 2016 Jul 19.
Primary Prophylaxis for Variceal Bleeding and the Improved Survival of Patients with Newly Diagnosed Hepatocellular Carcinoma
Kim JH11, Sinn DH2, Kim K3, Kang W1, Gwak GY1, Paik YH1, Choi MS1, Lee JH1, Koh KC1, Paik SW1.

Gut Liver. 2016 Nov 15;10(6):939-947. doi: 10.5009/gnl15527.
Lamivudine versus Entecavir for Newly Diagnosed Hepatitis B Virus-Related Hepatocellular Carcinoma
Kim JH11, Sinn DH1, Kim K2, Kim H2, Gwak GY1, Paik YH1, Choi MS1, Lee JH1, Koh KC1, Paik SW1.

Liver Int. 2016 Oct;36(10):1490-7. doi: 10.1111/liv.13107. Epub 2016 Mar 24.
The recommended treatment algorithms of the BCLC and HKLC staging systems: does following these always improve survival rates for HCC patients?
Kim KM11, Sinn DH2, Jung SH3, Gwak GY2, Paik YH2, Choi MS2, Lee JH2, Koh KC2, Paik SW4.

Gastroenterology. 2016 Sep;151(3):481-488.e1. doi: 10.1053/j.gastro.2016.06.001. Epub 2016 Jun 7.
Persistent Nonalcoholic Fatty Liver Disease Increases Risk for Carotid Atherosclerosis
Sinn DH11, Cho SJ2, Gu S3, Seong D4, Kang D5, Kim H6, Yi BK7, Paik SW1, Guallar E8, Cho J8, Gwak GY9.

Gut Liver. 2016 Sep 15;10(5):796-802. doi: 10.5009/gnl15368.
Prediction of the Risk of Hepatocellular Carcinoma in Chronic Hepatitis C Patients after Sustained Virological Response by Aspartate Aminotransferase to Platelet Ratio Index
Lee K11, Sinn DH1, Gwak GY1, Cho HC2, Jung SH3, Paik YH1, Choi MS1, Lee JH1, Koh KC1, Paik SW1.

Medicine (Baltimore). 2016 Aug;95(35):e4735. doi: 10.1097/MD.0000000000004735.
Factors determining long-term outcomes of hepatocellular carcinoma within the Milan criteria: liver transplantation versus locoregional therapy: A retrospective cohort study
Kim JH11, Sinn DH, Gwak GY, Choi GS, Kim JM, Kwon CH, Joh JW, Kim KY, Kim K, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW.

Springerplus. 2016 Aug 19;5(1):1365. doi: 10.1186/s40064-016-2920-z. eCollection 2016.
A randomized, controlled study of peginterferon lambda-1a/ribavirin +/- daclatasvir for hepatitis C virus genotype 2 or 3
Foster GR11, Chayama K2, Chuang WL3, Fainboim H4, Farkkila M5, Gadano A6, Gaeta GB7, Hezode C8, Inada Y9, Heo J10, Kumada H11, Lu SN12, Marcellin P13, Moreno C14, Roberts SK15, Strasser SI16, Thompson AJ17, Toyota J18, Paik SW19, Vierling JM20, Zignego AL21, Cohen D22, McPhee F23, Wind-Rotolo M24, Srinivasan S25, Hruska M26, Myler H27, Portsmouth SD28.

Cardiovasc Intervent Radiol. 2016 Jul;39(7):1015-22. doi: 10.1007/s00270-016-1314-5. Epub 2016 Mar 14.
Treatment of Small Hepatocellular Carcinoma (<= 2 cm) in the Caudate Lobe with Sequential Transcatheter Arterial Chemoembolization and Radiofrequency Ablation
Hyun D11, Cho SK2, Shin SW1, Rhim H1, Koh KC3, Paik SW3.

Oncotarget. 2016 Jul 26;7(30):47794-47807. doi: 10.18632/oncotarget.10026.
Effect of oral antiviral treatment on long-term outcomes of radiofrequency ablation therapy for hepatitis B virus-related hepatocellular carcinoma
Sohn W11,2, Kang TW3, Choi SK4, Jung SH4, Lee MW3, Lim HK3,5, Cho JY1,6, Shim SG7, Sinn DH1, Gwak GY1, Choi MS1, Lee JH1, Koh KC1, Paik SW1, Rhim H3, Paik YH1,5.

Ann Hepatol. 2016 May-Jun;15(3):333-49. doi: 10.5604/16652681.1198803.
Faldaprevir, pegylated interferon, and ribavirin for treatment-naive HCV genotype-1: pooled analysis of two phase 3 trials
Jensen DM11, Asselah T2, Dieterich D3, Foster GR4, Sulkowski MS5, Zeuzem S6, Mantry P7, Yoshida EM8, Moreno C9, Ouzan D10, Wright M11, Morano LE12, Buynak R13, Bourliere M14, Hassanein T15, Nishiguchi S16, Kao JH17, Omata M18, Paik SW19, Wong DK20, Tam E21, Kaita K22, Feinman SV23, Stern JO24, Scherer J, Quinson AM, Voss F25, Gallivan JP25, Bocher WO26, Ferenci P27.

Int J Hyperthermia. 2016 May;32(3):331-8. doi: 10.3109/02656736.2016.1144895. Epub 2016 Feb 25.
Combination treatment of trans-arterial chemo-embolisation, radiotherapy and hyperthermia (CERT) for hepatocellular carcinoma with portal vein tumour thrombosis: Interim analysis of prospective phase II trial
Yu JI11, Park HC1,2, Oh D1, Noh JM1, Jung SH1, Kim HY1, Shin SW3, Cho SK3, Sinn DH4, Paik YH4, Gwak GY4, Choi MS4, Lee JH4, Koh KC4, Paik SW4, Yoo BC5.

J Viral Hepat. 2016 May;23(5):358-65. doi: 10.1111/jvh.12499. Epub 2016 Feb 10.
A phase 3b study of sofosbuvir plus ribavirin in treatment-naive and treatment-experienced Korean patients chronically infected with genotype 2 hepatitis C virus
Ahn SH11, Lim YS2, Lee KS3, Paik SW4, Lee YJ5, Jeong SH6, Kim JH7, Yoon SK8, Yim HJ9, Tak WY10, Han SY11, Yang JC12, Mo H12, Mathias A12, Han L12, Knox SJ12, Brainard DM12, Kim YJ13, Byun KS14, Kim YS15, Heo J16, Han KH1.

JOURNAL OF KOREAN MEDICAL SCIENCE, MAY 2016, 31(5):825-826, DOI: 10.3346/jkms.2016.31.5.825
Anti-Viral Therapy for Compensated Liver Cirrhosis Patients with Normal Alanine Aminotransferase Response
Lee J1, Sinn DH, Paik SW

J Hepatol. 2016 May;64(5):1090-1098. doi: 10.1016/j.jhep.2016.01.012. Epub 2016 Jan 22.
Sorafenib or placebo plus TACE with doxorubicin-eluting beads for intermediate stage HCC: The SPACE trial
Lencioni R11, Llovet JM2, Han G3, Tak WY4, Yang J5, Guglielmi A6, Paik SW7, Reig M8, Kim DY9, Chau GY10, Luca A11, Del Arbol LR12, Leberre MA13, Niu W14, Nicholson K15, Meinhardt G16, Bruix J8.

World J Gastroenterol. 2016 Apr 14;22(14):3785-92. doi: 10.3748/wjg.v22.i14.3785.
Characteristics and outcomes of chronic liver disease patients with acute deteriorated liver function by severity of underlying liver disease
Hong YS11, Sinn DH1, Gwak GY1, Cho J1, Kang D1, Paik YH1, Choi MS1, Lee JH1, Koh KC1, Paik SW1.

Cancer Res Treat. 2016 Apr;48(2):574-82. doi: 10.4143/crt.2015.076. Epub 2015 Jul 17.
Do Biliary Complications after Hypofractionated Radiation Therapy in Hepatocellular Carcinoma Matter?
Yu JI11, Park HC1, Lim DH1, Paik SW2.

Gut Liver. 2016 Mar;10(2):295-302. doi: 10.5009/gnl15155.
Relationship between Controlled Attenuation Parameter and Hepatic Steatosis as Assessed by Ultrasound in Alcoholic or Nonalcoholic Fatty Liver Disease
Ahn JM11, Paik YH1, Min SY1, Cho JY1, Sohn W1, Sinn DH1, Gwak GY1, Choi MS1, Lee JH1, Koh KC1, Paik SW1, Yoo BC1.

Medicine (Baltimore). 2016 Jan;95(3):e2578. doi: 10.1097/MD.0000000000002578.
Nonalcoholic Fatty Liver Disease for Identification of Preclinical Carotid Atherosclerosis
Sinn DH11, Cho SJ, Gwak GY, Cho J, Gu S, Seong D, Kang D, Kim H, Yi BK, Paik SW.

Dig Dis Sci. 2015 Dec;60(12):3794-800. doi: 10.1007/s10620-015-3812-8. Epub 2015 Jul 28.
Stopping Preemptive Antiviral Therapy for Hepatitis B Virus Can Be Considered for Patients with Favorable Predictors
Kim HJ11, Sinn DH2, Kim NJ1, Kim JH1, Kim E1, Gwak GY1, Paik YH1, Choi MS1, Lee JH1, Koh KC1, Paik SW1, Yoo BC1.

PLoS One. 2015 Dec 22;10(12):e0144777. doi: 10.1371/journal.pone.0144777. eCollection 2015.
Prediction of Clinical Outcomes in Hepatitis B E Antigen Negative Chronic Hepatitis B Patients with Elevated Hepatitis B Virus DNA Levels
Ahn JM11,2, Sinn DH1, Gwak GY1, Paik YH1, Choi MS1, Lee JH1, Koh KC1, Paik SW1.

J Korean Med Sci. 2015 Nov;30(11):1618-24. doi: 10.3346/jkms.2015.30.11.1618. Epub 2015 Oct 16.
Hepatocellular Carcinoma Risk of Compensated Cirrhosis Patients with Elevated HBV DNA Levels according to Serum Aminotransferase Levels
Lee J11, Sinn DH1, Kim JH1, Gwak GY1, Kim HS2, Jung SH2, Paik YH1, Choi MS1, Lee JH1, Koh KC1, Yoo BC1, Paik SW1.

Hepatology. 2015 Sep;62(3):694-701. doi: 10.1002/hep.27889. Epub 2015 Jul 3.
Hepatocellular carcinoma risk in chronic hepatitis B virus-infected compensated cirrhosis patients with low viral load
Sinn DH11, Lee J1, Goo J2, Kim K2, Gwak GY1, Paik YH1, Choi MS1, Lee JH1, Koh KC1, Yoo BC1, Paik SW1.

J Viral Hepat. 2015 Jun;22(6):539-50. doi: 10.1111/jvh.12356. Epub 2014 Nov 7.
Influence of hepatitis B virus reactivation on the recurrence of HBV-related hepatocellular carcinoma after curative resection in patients with low viral load
Sohn W11, Paik YH, Cho JY, Ahn JM, Choi GS, Kim JM, Kwon CH, Joh JW, Sinn DH, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC.

Radiology. 2015 Jun;275(3):908-19. doi: 10.1148/radiol.15141483. Epub 2015 Feb 16.
Small Hepatocellular Carcinoma: Radiofrequency Ablation versus Nonanatomic Resection-Propensity Score Analyses of Long-term Outcomes
Kang TW11, Kim JM, Rhim H, Lee MW, Kim YS, Lim HK, Choi D, Song KD, Kwon CH, Joh JW, Paik SW, Paik YH, Ahn JH.

J Hepatol. 2015 May;62(5):1112-21. doi: 10.1016/j.jhep.2014.12.009. Epub 2014 Dec 13.
Sorafenib therapy for hepatocellular carcinoma with extrahepatic spread: Treatment outcome and prognostic factors
Sohn W11, Paik YH2, Cho JY1, Lim HY1, Ahn JM1, Sinn DH1, Gwak GY1, Choi MS1, Lee JH1, Koh KC1, Paik SW1, Yoo BC1.

PLoS One. 2015 Apr 29;10(4):e0124434. doi: 10.1371/journal.pone.0124434. eCollection 2015.
Different Survival of Barcelona Clinic Liver Cancer Stage C Hepatocellular Carcinoma Patients by the Extent of Portal Vein Invasion and the Type of Extrahepatic Spread
Sinn DH11, Cho JY1, Gwak GY1, Paik YH1, Choi MS1, Lee JH1, Koh KC1, Paik SW1, Yoo BC1.

Cancer Res Treat. 2015 Apr;47(2):251-8. doi: 10.4143/crt.2014.011. Epub 2014 Oct 27.
Changes in Arterioportal Shunts in Hepatocellular Carcinoma Patients with Portal Vein Thrombosis Who Were Treated with Chemoembolization Followed by Radiotherapy
Oh D11, Shin SW2, Park HC1, Cho SK2, Lim do H1, Paik SW3.

Digestion. 2015;91(2):150-7. doi: 10.1159/000369789. Epub 2015 Feb 11.
Association between Serum Osteocalcin Levels and Non-Alcoholic Fatty Liver Disease in Women
Sinn DH11, Gwak GY, Rhee SY, Cho J, Son HJ, Paik YH, Choi MS, Lee JH, Koh KC, Yoo BC, Paik SW.

Hepatogastroenterology. 2015 Mar-Apr;62(138):399-404.
Intrahepatic Metastasis is More Risky than Multiple Occurrence in Hepatocellular Carcinoma Patients after Curative Liver Resection
Kim JM1, Kwon CH, Joh JW, Park JB, Lee JH, Kim SJ, Paik SW, Park CK.

Hepatogastroenterology. 2015 Mar-Apr;62(138):286-90.
Synchronous and Metachronous Colorectal Cancers: Distinct Disease Entities or Different Disease Courses
Huang CS1, Yang SH, Lin CC, Lan YT, Chang SC, Wang HS, Chen WS, Lin TC, Lin JK, Jiang JK.

Medicine (Baltimore). 2015 Feb;94(6):e450. doi: 10.1097/MD.0000000000000450.
Incidental Microscopic Bile Duct Tumor Thrombi in Hepatocellular Carcinoma after Curative Hepatectomy A Matched Study
Kim JM11, Kwon CH, Joh JW, Sinn DH, Park JB, Lee JH, Kim SJ, Paik SW, Park CK, Yoo BC.

Am J Surg. 2015 Feb;209(2):391-7. doi: 10.1016/j.amjsurg.2013.06.010.
Hepatectomy is a reasonable option for older patients with hepatocellular carcinoma
Kim JM11, Cho BI1, Kwon CH1, Joh JW2, Park JB1, Lee JH3, Kim SJ1, Paik SW3, Park CK4.

Korean J Intern Med. 2015 Jan;30(1):32-41. doi: 10.3904/kjim.2015.30.1.32. Epub 2014 Dec 30.
Long-term efficacy of tenofovir disoproxil fumarate therapy after multiple nucleos(t)ide analogue failure in chronic hepatitis B patients
Kim HJ11, Cho JY1, Kim YJ1, Gwak GY1, Paik YH1, Choi MS1, Koh KC1, Paik SW1, Yoo BC1, Lee JH1.

J Surg Oncol. 2014 Dec;110(8):976-81. doi: 10.1002/jso.23772. Epub 2014 Aug 29.
Outcomes After Curative Hepatectomy in Patients with Non-B Non-C Hepatocellular Carcinoma And Hepatitis B Virus Hepatocellular Carcinoma From Non-Cirrhotic Liver
Kim JM11, Kwon CH, Joh JW, Park JB, Lee JH, Kim SJ, Paik SW, Park CK, Yoo BC.

Gut. 2014 Dec;63(12):1943-50. doi: 10.1136/gutjnl-2013-306409. Epub 2014 Mar 10.
Patients with chronic hepatitis B treated with oral antiviral therapy retain a higher risk for HCC compared with patients with inactive stage disease
Cho JY11, Paik YH1, Sohn W1, Cho HC2, Gwak GY1, Choi MS1, Lee JH1, Koh KC1, Paik SW1, Yoo BC1.

PLoS One. 2014 Nov 5;9(11):e112184. doi: 10.1371/journal.pone.0112184. eCollection 2014.
Comparison of Clinical Manifestations and Outcomes between Hepatitis B Virus- and Hepatitis C Virus-Related Hepatocellular Carcinoma: Analysis of a Nationwide Cohort
Sinn DH11, Gwak GY1, Cho J2, Paik SW1, Yoo BC1.

Tumori. 2014 Nov-Dec;100(6):645-51. doi: 10.1700/1778.19270.
Child-Pugh score maintenance in cirrhotic hepatocellular carcinoma patients after radiotherapy: aspects of gastroduodenal complications
Yu JI1, Cho JY, Park HC, Lim do H, Gwak GY, Paik SW.

Dig Liver Dis. 2014 Sep;46(9):813-7. doi: 10.1016/j.dld.2014.05.003. Epub 2014 Jun 2.
A prediction model for liver abscess developing after transarterial chemoembolization in patients with hepatocellular carcinoma
Shin JU11, Kim KM2, Shin SW3, Min SY4, Park SU4, Sinn DH4, Gwak GY4, Choi MS4, Lee JH4, Paik SW4, Yoo BC4, Koh KC5.

Gut Liver. 2014 Sep;8(5):543-51. doi: 10.5009/gnl13356. Epub 2014 Jul 25.
Role of Radiofrequency Ablation in Patients with Hepatocellular Carcinoma Who Undergo Prior Transarterial Chemoembolization: Long-Term Outcomes and Predictive Factors
Sohn W11, Choi MS1, Cho JY1, Gwak GY1, Paik YH1, Lee JH1, Koh KC1, Paik SW1, Yoo BC1.

Hepatogastroenterology. 2014 Sep;61(134):1704-11.
Hepatitis B Virus Reactivation During Anti-Cancer Chemotherapy in Patients with Past Hepatitis B Virus Infection
Kim E1, Yune S, Ha JM, Lee WJ, Hwang JW, Paik YH, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC.

Liver Transpl. 2014 Sep;20(9):1057-63. doi: 10.1002/lt.23919.
Time of Hepatocellular Carcinoma Recurrence After Liver Resection and Alpha-Fetoprotein Are Important Prognostic Factors for Salvage Liver Transplantation
Lee S11, Hyuck David Kwon C, Man Kim J, Joh JW, Woon Paik S, Kim BW, Wang HJ, Lee KW, Suh KS, Lee SK.

Aliment Pharmacol Ther. 2014 Sep;40(6):695-704. doi: 10.1111/apt.12875. Epub 2014 Jul 30.
Proton pump inhibitor use significantly increases the risk of spontaneous bacterial peritonitis in 1965 patients with cirrhosis and ascites: a propensity score matched cohort study
Min YW11, Lim KS, Min BH, Gwak GY, Paik YH, Choi MS, Lee JH, Kim JJ, Koh KC, Paik SW, Yoo BC, Rhee PL.

J Korean Med Sci. 2014 Aug;29(8):1113-9. doi: 10.3346/jkms.2014.29.8.1113. Epub 2014 Jul 30.
Relationship of Liver Stiffness and Controlled Attenuation Parameter Measured by Transient Elastography with Diabetes Mellitus in Patients with Chronic Liver Disease
Ahn JM11, Paik YH1, Kim SH1, Lee JH1, Cho JY1, Sohn W1, Gwak GY1, Choi MS1, Lee JH1, Koh KC1, Paik SW1, Yoo BC1.

Ann Surg Oncol. 2014 Jul;21(7):2429-35. doi: 10.1245/s10434-014-3621-x. Epub 2014 Mar 12.
HBV DNA and HBsAg Levels as Risk Predictors of Early and Late Recurrence after Curative Resection of HBV-related Hepatocellular Carcinoma
Sohn W11, Paik YH, Kim JM, Kwon CH, Joh JW, Cho JY, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC.

Int J Radiat Oncol Biol Phys. 2014 Jul 15;89(4):814-21. doi: 10.1016/j.ijrobp.2014.03.020.
The Role of Diffusion-Weighted Magnetic Resonance Imaging in the Treatment Response Evaluation of Hepatocellular Carcinoma Patients Treated With Radiation Therapy
Yu JI11, Park HC2, Lim DH1, Choi Y1, Jung SH1, Paik SW3, Kim SH4, Jeong WK4, Kim YK4.

Atherosclerosis. 2014 Jun;234(2):270-5. doi: 10.1016/j.atherosclerosis.2014.03.001. Epub 2014 Mar 21.
Modest alcohol consumption and carotid plaques or carotid artery stenosis in men with non-alcoholic fatty liver disease
Sinn DH11, Gwak GY2, Cho J3, Son HJ4, Paik YH5, Choi MS5, Lee JH5, Koh KC5, Paik SW5, Yoo BC5.

Liver Int. 2014 May;34(5):795-801. doi: 10.1111/liv.12445. Epub 2014 Jan 12.
The feasibility of combined transcatheter arterial chemoembolization and radiotherapy for advanced hepatocellular carcinoma
Cho JY11, Paik YH, Park HC, Yu JI, Sohn W, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC.

J Gastroenterol Hepatol. 2014 May;29(5):1043-8. doi: 10.1111/jgh.12504.
Long- term survival after surgical resection for huge hepatocellular carcinoma: Comparison with transarterial chemoembolization after propensity score matching
Min YW11, Lee JH, Gwak GY, Paik YH, Lee JH, Rhee PL, Koh KC, Paik SW, Yoo BC, Choi MS.

World J Gastroenterol. 2014 Apr 14;20(14):4059-65. doi: 10.3748/wjg.v20.i14.4059.
Single hepatocellular carcinoma <= 3 cm in left lateral segment: Liver resection or radiofrequency ablation
Kim JM11, Kang TW1, Kwon CH1, Joh JW1, Ko JS1, Park JB1, Rhim H1, Lee JH1, Kim SJ1, Paik SW1.

Transplant Proc. 2014 Apr;46(3):726-9. doi: 10.1016/j.transproceed.2013.11.037.
Expanded Criteria for Liver Transplantation in Patients with Hepatocellular Carcinoma
Kim JM11, Kwon CH1, Joh JW2, Park JB1, Lee JH3, Kim GS4, Kim SJ1, Paik SW3, Lee SK1.

Scand J Gastroenterol. 2014 Mar;49(3):373-80. doi: 10.3109/00365521.2013.871745. Epub 2013 Dec 19.
Predisposing factors for recurrence of HBV-related small hepatocellular carcinoma after percutaneous radiofrequency ablation
Sohn W11, Paik YH, Lee MW, Rhim H, Lim HK, Cho JY, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC.

Ann Surg Treat Res. 2014 Mar;86(3):122-9. doi: 10.4174/astr.2014.86.3.122. Epub 2014 Feb 24.
Can the model for end-stage liver disease score replace the indocyanine green clearance test in the selection of right hemihepatectomy in Child-Pugh class A
Kim JM11, Kwon CH1, Joh JW1, Park JB1, Lee JH2, Kim GS3, Kim SJ1, Paik SW2.

Ann Surg Oncol. 2014 Feb;21(2):458-65. doi: 10.1245/s10434-013-3302-1. Epub 2013 Oct 17.
Differences Between Hepatocellular Carcinoma and Hepatitis B Virus Infection in Patients With and Without Cirrhosis
Kim JM11, Kwon CH, Joh JW, Park JB, Lee JH, Kim SJ, Paik SW, Park CK, Yoo BC.

Liver Int. 2014 Feb;34(2):174-83. doi: 10.1111/liv.12314. Epub 2013 Nov 20.
Re-evaluating transarterial chemoembolization for the treatment of Hepatocellular Carcinoma: Consensus recommendations and review by an International Expert Panel
Cheng AL11, Amarapurkar D, Chao Y, Chen PJ, Geschwind JF, Goh KL, Han KH, Kudo M, Lee HC, Lee RC, Lesmana LA, Lim HY, Paik SW, Poon RT, Tan CK, Tanwandee T, Teng G, Park JW.

Gut Liver. 2014 Jan;8(1):58-63. doi: 10.5009/gnl.2014.8.1.58. Epub 2013 Nov 21.
Clinical Features, Image Findings, and Prognosis of Inflammatory Pseudotumor of the Liver: A Multicenter Experience of 45 Cases
Park JY11, Choi MS1, Lim YS2, Park JW2, Kim SU3, Min YW1, Gwak GY1, Paik YH1, Lee JH1, Koh KC1, Paik SW1, Yoo BC1.

J Clin Oncol. 2013 Oct 1;31(28):3517-24. doi: 10.1200/JCO.2012.48.4410. Epub 2013 Aug 26.
Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study
Johnson PJ11, Qin S, Park JW, Poon RT, Raoul JL, Philip PA, Hsu CH, Hu TH, Heo J, Xu J, Lu L, Chao Y, Boucher E, Han KH, Paik SW, Robles-Avi?a J, Kudo M, Yan L, Sobhonslidsuk A, Komov D, Decaens T, Tak WY, Jeng LB, Liu D, Ezzeddine R, Walters I, Cheng AL.

Gut Liver. 2013 Sep;7(5):585-93. doi: 10.5009/gnl.2013.7.5.585. Epub 2013 Aug 14.
Pegylated Interferon and Ribavirin in the Retreatment of Chronic Hepatitis C in Korea
Cho HC11, Gwak GY, Paik YH, Choi MS, Lee JH, Koh KC, Yoo BC, Paik SW.

Liver Int. 2013 Mar;33(3):327-37. doi: 10.1111/liv.12083. Epub 2013 Jan 18.
Consensus recommendations and review by an International Expert Panel on Interventions in Hepatocellular Carcinoma (EPOIHCC)
Park JW11, Amarapurkar D, Chao Y, Chen PJ, Geschwind JF, Goh KL, Han KH, Kudo M, Lee HC, Lee RC, Lesmana LA, Lim HY, Paik SW, Poon RT, Tan CK, Tanwandee T, Teng G, Cheng AL.

Hepatol Int. 2012 Oct;6(4):696-706. doi: 10.1007/s12072-011-9314-7. Epub 2011 Oct 12.
Telbivudine in combination with adefovir versus adefovir monotherapy in HBeAg-positive, lamivudine-resistant chronic hepatitis B
Ahn SH11, Kweon YO2, Paik SW3, Sohn JH4, Lee KS5, Kim DJ6, Piratvisuth T7, Yuen MF8, Chutaputti A9, Chao YC10, Trylesinski A11, Avila C12.

J Gastroenterol Hepatol. 2012 Sep;27(9):1454-60. doi: 10.1111/j.1440-1746.2011.07050.x.
Viral response at 6 months is associated with treatment outcome of adefovir add-on therapy for lamivudine-resistance
Kim YJ11, Paik SW, Sinn DH, Gwak GY, Choi MS, Lee JH, Koh KC, Yoo BC.

Gut Liver. 2012 Apr;6(2):241-8. doi: 10.5009/gnl.2012.6.2.241. Epub 2012 Apr 17.
The Clinical and Laboratory Characteristics of Patients with Chronic Hepatitis B Using Current or Past Antiviral Therapy in Korea: A Multi-Center, Nation-Wide, Cross-Sectional Epidemiologic Study
Choi MS11, Sinn DH, Kim SA, Lee YS, Choi W, Paik SW.

Hepatogastroenterology. 2012 Jan-Feb;59(113):1-6. doi: 10.5754/hge11387.
Ribavirin Dose and Treatment Outcome of Korean Patients with Genotype 1 Chronic Hepatitis C
Sinn DH11, Kim J, Shin SR, Gwak GY, Choi MS, Lee JH, Koh KC, Yoo BC, Paik SW.

Gut Liver. 2011 Dec;5(4):500-5. doi: 10.5009/gnl.2011.5.4.500. Epub 2011 Nov 21.
Comparison of the Clinical Features of Hepatitis A between HBsAg-Positive and HBsAg-Negative Patients
Kim KM11, Eo SJ, Gwak GY, Choi MS, Lee JH, Koh KC, Yoo BC, Paik SW.

J Gastroenterol Hepatol. 2011 Sep;26(9):1374-9. doi: 10.1111/j.1440-1746.2011.06744.x.
Association of a single nucleotide polymorphism near the interleukin-28B gene with response to hepatitis C therapy in Asian patients
Sinn DH11, Kim YJ, Lee ST, Gwak GY, Choi MS,